Trial intelligence / Profile preview

Effects of common topical glaucoma therapy on optic nerve head blood flow autoregulation in healthy humans

2005-005895-34Phase 4Terminated

Sponsor
Department of Clinical Pharmacology, Medical University of Vienna
Start
Jan 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of timolol, dorzolamide and brimonidine in Glaucoma (3 arms), sponsored by Department of Clinical Pharmacology, Medical University of Vienna. Started Jan 2006; status: terminated.

02

Drugs

timololdorzolamidebrimonidine
03

Conditions

Glaucoma

Beyond the preview

Go deeper on 2005-005895-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-005895-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call